Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Hualing Heparin is a specialized pharmaceutical company based in Wuhan, China, focusing on the production and export of heparin-related active pharmaceutical ingredients (APIs). The company primarily manufactures Heparin Sodium and Heparin Lithium derived from porcine intestinal mucosa under strict GMP conditions. It serves as a key supplier in the global anticoagulant market, adhering to international quality standards such as USP and EP. Their business model centers on high-volume biological extraction and chemical purification for the healthcare industry. The company operates a large-scale production facility in the Yangluo Economic Development Zone to support its global distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Hualing Heparin.